Worse Survival Seen for Alternative Versus Usual Cancer Therapy

Share this content:
The choice of alternative medicine for some cancers may increase a patient's risk.
The choice of alternative medicine for some cancers may increase a patient's risk.

(HealthDay News) -- Patients who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, according to research published online Aug. 10 in the Journal of the National Cancer Institute.

Using the National Cancer Database, which represents approximately 70 percent of newly diagnosed cancers nationwide, the researchers studied 840 patients with breast, prostate, lung, and colorectal cancers. The researchers compared 280 patients who chose alternative medicine alone to 560 patients who underwent conventional cancer treatment. The researchers followed the patients from 2004 to 2013.

The investigators found that those patients who received alternative therapy instead of the usual treatments were more likely to die during the study. Alternative medicine was independently associated with greater risk of death compared with conventional cancer treatment overall (hazard ratio [HR], 2.50), as well as in subgroups with breast (HR, 5.68), lung (HR, 2.17), and colorectal cancer (HR, 4.57).

"We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," lead author Skyler Johnson, M.D., from the Yale School of Medicine and Yale Cancer Center in New Haven, Conn., said in a school news release. "It is our hope that this information can be used by patients and physicians when discussing the impact of cancer treatment decisions on survival."

Abstract/Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs